Issued Patents All Time
Showing 51–75 of 160 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10544392 | Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood | Alena Gros | 2020-01-28 |
| 10406177 | Modified cells and methods of therapy | Branden Moriarity, Beau Webber, Modassir Choudhry, Douglas C. Palmer, Nicholas P. Restifo | 2019-09-10 |
| 10407485 | Murine anti-NY-ESO-1 T cell receptors | Maria R. Parkhurst, Richard A. Morgan, Shannon Faith Rosati | 2019-09-10 |
| 10329339 | Anti-human papillomavirus 16 E6 T cell receptors | Christian S. Hinrichs | 2019-06-25 |
| 10322146 | Methods of conditioning patients for T cell therapy | Adrian Bot, Jeffrey S. Wiezorek, William Go, Rajul JAIN, James N. Kochenderfer | 2019-06-18 |
| 10251912 | MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 | Rong Wang, Gang Zeng | 2019-04-09 |
| 10174098 | Anti-human papillomavirus 16 E7 T cell receptors | Christian S. Hinrichs | 2019-01-08 |
| 10166255 | Intracellular genomic transplant and methods of therapy | Branden Moriarity, Beau Webber, R. Scott McIvor, Modassir Choudhry, Douglas C. Palmer +1 more | 2019-01-01 |
| 10143724 | Anti-SSX-2 T cell receptors and related materials and methods of use | Richard A. Morgan, Nachimuthu Chinnasamy | 2018-12-04 |
| 10087230 | Murine anti-NY-ESO-1 T cell receptors | Maria R. Parkhurst, Richard A. Morgan, Shannon Faith Rosati | 2018-10-02 |
| 9879065 | T cell receptors recognizing MHC class II-restricted MAGE-A3 | Paul F. Robbins, Xin Yao | 2018-01-30 |
| 9855298 | Methods of conditioning patients for T cell therapy | Adrian Bot, Jeffrey S. Wiezorek, William Go, Rajul JAIN, James N. Kochenderfer | 2018-01-02 |
| 9844569 | Methods of producing enriched populations of tumor reactive T cells from peripheral blood | Alena Gros | 2017-12-19 |
| 9822162 | Anti-human papillomavirus 16 E6 T cell receptors | Christian S. Hinrichs | 2017-11-21 |
| 9688739 | T cell receptors and related materials and methods of use | Richard A. Morgan, Timothy L. Frankel | 2017-06-27 |
| 9624306 | Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer | Richard A. Morgan | 2017-04-18 |
| 9522955 | Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer | Dhanalakshmi Chinnasamy | 2016-12-20 |
| 9522948 | GP100-specific T cell receptors and related materials and methods of use | Nicholas P. Restifo, Lydie Cassard, Zhiya Yu | 2016-12-20 |
| 9487573 | Murine anti-NY-ESO-1 T cell receptors | Maria R. Parkhurst, Richard A. Morgan, Shannon Faith Rosati | 2016-11-08 |
| 9447144 | MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 | Rong Wang, Gang Zeng | 2016-09-20 |
| 9359447 | Anti-mesothelin chimeric antigen receptors | Steven A. Feldman, Ira H. Pastan | 2016-06-07 |
| 9345748 | Anti-SSX-2 T cell receptors and related materials and methods of use | Richard A. Morgan, Nachimuthu Chinnasamy | 2016-05-24 |
| 9266960 | Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer | Richard A. Morgan | 2016-02-23 |
| 9128080 | Modified T cell receptors and related materials and methods | Paul F. Robbins, Richard A. Morgan | 2015-09-08 |
| 9074185 | Adoptive cell therapy with young T cells | Mark E. Dudley | 2015-07-07 |